SEARCH
YOUR SEARCH FOR Text 261 RESULTS
251 of Total
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
252 of Total
Incyte to Present at Upcoming Investor Conferences
253 of Total
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Br
254 of Total
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult a
255 of Total
Incyte to Report Third Quarter Financial Results
256 of Total
Incyte Honors the 2026 MPN Heroes®, Celebrating Champions of the Myeloproliferative Neoplasm (MPN) C
257 of Total
Incyte Events
258 of Total
Incyte News Releases
259 of Total
Incyte SEC Filings
260 of Total